Innate Pharma SA
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
other
SEC Category
Accelerated filer
State of Incorporation
France
Country
France
Business Address
117 AVENUE DE LUMINY, MARSEILLE, , 13009
Mailing Address
117 AVENUE DE LUMINY, MARSEILLE, , 13009
Phone
33430303030
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2024
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 20-F Foreign company annual report | April 1, 2026 | View on SEC |
| 6-K Foreign company current report | March 26, 2026 | View on SEC |
| 6-K Foreign company current report | March 19, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 4, 2026 | View on SEC |
| 6-K Foreign company current report | February 18, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | February 6, 2026 | View on SEC |
| 6-K Foreign company current report | January 7, 2026 | View on SEC |
| 6-K Foreign company current report | December 22, 2025 | View on SEC |
| 6-K Foreign company current report | December 11, 2025 | View on SEC |
| 6-K Foreign company current report | November 28, 2025 | View on SEC |
Annual Reports
20-F
April 1, 2026
- Strategic partnership model with industry giants like AstraZeneca, Sanofi, and Takeda reduces late-stage clinical trial costs.
- Focus on innovative immuno-oncology and NK cell technology provides a specialized niche in the biotech sector.
Related Companies
Companies in the same industry (SIC: 2836)
Scinai Immunotherapeutics Ltd.
SCNI
Biological Products, (No Diagnostic Substances)
Genenta Science S.p.A.
GNTA
Biological Products, (No Diagnostic Substances)
Greenland Mines Ltd
GRML
Biological Products, (No Diagnostic Substances)
Kymera Therapeutics, Inc.
KYMR
Biological Products, (No Diagnostic Substances)
Black Hawk Acquisition Corp
BKHA
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.